About NAD
What is NAD⁺ NAD⁺ Precursors Scientific Analysis Press
Clinical Studies Preclinical Studies
What is NAD⁺NAD⁺ Precursors Studies Clinical Studies Preclinical Studies Scientific AnalysisPress
About NAD
Our mission is to provide a balanced look at NAD’s role in human health by providing the latest educational and scientifically proven content to the public.

Variable Selection in Untargeted Metabolomics and the Danger of Sparsity


Objective

To study the metabolic effects of treatment with NR in a cohort of patients with ataxia-telangiectasia (AT).

Study Design

Comparative study in 14 patients with AT

Dose

25 mg/kg

Duration

4 months

Key Outcomes

  • NR-related pathways and metabolites significantly increased after NR supplementation.

Published Study

Clinical, Ataxia Telangiectasia, Neurological HealthANAD StaffNovember 17, 2020
Facebook0 Twitter 0 Likes
Previous

Nicotinamide Riboside Supplementation Does Not Alter Whole-Body or Skeletal Muscle Metabolic Responses to a Single Bout of Endurance Exercise

Clinical, Muscle HealthANAD StaffJanuary 25, 2021
Next

Boosting NAD Level Suppresses Inflammatory Activation of PBMCs in Heart Failure

Clinical, Cardiovascular HealthANAD StaffAugust 13, 2020

Advance Your NAD+ knowledge

Subscribe for the latest in NAD+ and nicotinamide riboside (NR) clinical and preclinical research news. Delivered straight to your inbox.

Thank you!

ARTICLE CATEGORIES

  • Scientific Analysis

  • Studies

  • Press

WHAT IS NAD⁺

  • A Timeline to NAD Research

  • A Brief Introduction to NAD

  • NAD Levels Are Not Constant

  • Improving NAD Status to Support Cellular Resilience

  • NAD Biosynthesis & Metabolome

  • Glossary

About

  • About Us

  • Frequently Asked Questions

Stay Connected

Scientific Analysis RSS
Clinical Studies RSS
Press RSS
RSS Block
Select a Blog Page to create an RSS feed link. Learn more
RSS

© Copyright 2020 AboutNAD

Terms of Use,  Privacy Policy,  California Consumer Privacy Statement,  Consumer Health Data Privacy Statement and  Accessibility Statement   Accessibility Statement Logo

AboutNAD is curated by Niagen Bioscience, Inc. and the content of this site is intended for educational purposes only.